ARCHIVES

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Maguire Backs Cancer Program But Insists On New Emphasis for Prevention

January 26, 1979

Funding Opportunities.

March 15, 2002

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Carbone Heads Chairmen’s Group

June 30, 1978

NCAB working Group Is Not Subject To Open Meetings Law, NCI Official Says

December 9, 1994

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013